Aktieanalys

Moberg Pharma: On path to become the Global Leader - Redeye

{newsItem.title}

Redeye Publicerad: 18 Mar 2022 15:10

Redeye regards this morning’s news about the regulatory submission of the North American phase 3 study as very positive.

Länk till analysen i sin helhet: https://www.redeye.se/research/836567/moberg-pharma-on-path-to-become-the-global-leader?utm_source=finwire&utm_medium=RSS

Nyheter om Moberg Pharma

Läses av andra just nu

Om aktien Moberg Pharma

Senaste nytt